NCT05609916View on ClinicalTrials.gov

CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

December 30, 2026

Study Completion Date

August 30, 2027

Conditions
Cognitive Behavioral TherapyObsessive-Compulsive DisorderObsessive-Compulsive Disorder in ChildrenObsessive-Compulsive Disorder in Adolescence
Interventions
BEHAVIORAL

Cognitive Behavioral Therapy

"During Phase I, participants will receive open label (no blinding) CBT during their study participation for 12 to 18 weeks.~During Phase II, participants will continue receiving CBT maintenance sessions every two weeks for the first 4 weeks, followed by sessions every four weeks. They will also meet with the study physician every 2 weeks via telepsychiatry appointments for clinical and scalar assessment."

Trial Locations (1)

77030

RECRUITING

Baylor College of Medicine, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER